About Idoven
Idoven has developed the world's first cardiology-as-a-service platform powered by AI that augments a clinician's ability to identify, triage and diagnose patients at scale.
Mission & Story
Founding Story
Founded following Iker Casillas' heart attack on May 1, 2019 during training at age 38. The World Cup-winning goalkeeper now relies on Idoven to care for his heart. Together with the Iker Casillas Foundation, Idoven impacts vulnerable groups at high risk of cardiovascular diseases.
Clinical Focus
Medical conditions and clinical areas addressed by Idoven.
Who It Serves
Milestones & Awards
Recent Milestones
AstraZeneca and Idoven launched CONCERTO project (2024-2027) to improve early diagnosis of amyloidosis. FAITHFUL Consortium launched (2024-2025) with €1.7 million from EIT Health Spain involving 14 international institutions. Featured on cover of Forward: Unlocking Europe's AI Potential (September 2025).
Awards & Recognition
Recognized and supported by leading institutions. Featured on Forward magazine cover for AI potential.
Key Partnerships
Social & Media
Follow on
Latest Updates
Basketball Legend Pau Gasol joins Healthtech Scaleup Idoven in a new round of investment to sustain exceptional growth
AstraZeneca and Idoven launch the CONCERTO project to improve early diagnosis of patients with amyloidosis
Willem, Idoven’s AI Platform, achieves 96.4% accuracy in atrial fibrillation detection from 1-lead ECGs
Company Details
- Founded
- 2018
- Headquarters
- Madrid, Spain
- Employees
- 80
- Stage
- series b
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.